Last reviewed · How we verify

NCT03619265: 114-012

Evaluation of Activity Levels, Inflammatory Markers, and Overall Wellness.

Completed NA Last updated 12 March 2020
What this trial tests

NA trial testing Prickly pear juice in Range of Motion in 40 participants. Completed in 10 February 2020.

Timeline
17 July 2018
Primary endpoint
25 June 2019
10 February 2020

Quick facts

Lead sponsorNatural Immune Systems Inc
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment40
Start date17 July 2018
Primary completion25 June 2019
Estimated completion10 February 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Natural Immune Systems Inc

Who can join

Adults 35 to 75, any sex, with Range of Motion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose for this protocol is to perform a double-blind, randomized, placebo-controlled, parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical product on physical and mental energy levels and overall wellness.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Improved Joint Mobility Associated with Reduced Inflammation Related to Consumption of Nopal Cactus Fruit Juice: Results from a Placebo-Controlled Trial Using Digital Inclinometry to Objectively Document Mobility of All Major Joints.
    Jensen GS. · · 2020 · cited 1× · PMID 33328728 · DOI 10.2147/cia.s267451

Verify or expand the search:

Other recruiting trials for Range of Motion

Currently open trials in the same condition.

Other Natural Immune Systems Inc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03619265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing